ASP Isotopes (NASDAQ:ASPI) Stock Price Up 6.8% – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI) rose 6.8% on Thursday . The company traded as high as $6.15 and last traded at $6.0640. Approximately 3,138,569 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 5,340,346 shares. The stock had previously closed at $5.68.

Analysts Set New Price Targets

ASPI has been the topic of several recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Cantor Fitzgerald initiated coverage on ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price target on the stock. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Price Performance

The stock’s fifty day moving average price is $6.24 and its 200-day moving average price is $7.62. The company has a debt-to-equity ratio of 1.04, a current ratio of 6.14 and a quick ratio of 6.10. The firm has a market cap of $659.72 million, a price-to-earnings ratio of -4.61 and a beta of 3.55.

Insider Activity at ASP Isotopes

In related news, COO Robert Ainscow sold 8,438 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $5.44, for a total transaction of $45,902.72. Following the transaction, the chief operating officer directly owned 1,537,817 shares of the company’s stock, valued at approximately $8,365,724.48. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Heather Kiessling sold 80,000 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $5.80, for a total transaction of $464,000.00. Following the completion of the transaction, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. This represents a 9.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently modified their holdings of ASPI. Quantbot Technologies LP bought a new position in ASP Isotopes during the third quarter worth $34,000. Ameritas Investment Partners Inc. increased its holdings in shares of ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after buying an additional 1,600 shares in the last quarter. BNP Paribas Financial Markets raised its stake in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares during the last quarter. IFP Advisors Inc acquired a new position in shares of ASP Isotopes in the 4th quarter worth approximately $48,000. Finally, Pictet Asset Management Holding SA acquired a new position in shares of ASP Isotopes in the 4th quarter worth approximately $61,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.